Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Hamstra

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Molecular Pharmacology|November 6, 2007
Revoking the privilege: targeting HER2 in the central nervous systemJoseph N Contessa, Daniel A Hamstra
International Journal of Radiation Oncology, Biology, Physics|June 25, 2021
Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient ExperienceJacob S Parzen, Daniel A Hamstra
Pediatric Blood & Cancer|February 15, 2008
Radiation therapy reduces local failure and improves overall survival in sPNETAaron C Spalding, Daniel A Hamstra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to G. Gandaglia et al and K. LuDean A Shumway, Daniel A Hamstra
Translational Andrology and Urology|July 18, 2020
Local control mattersRonald B Levitin, Daniel A Hamstra
Frontiers in Oncology|October 13, 2012
General commentary to the "management of biochemical recurrence after primary localized therapy for prostate cancer" by darwish o. M. And raj g. VMark Shilkrut, Felix Feng, Daniel A Hamstra
The Annals of Thoracic Surgery|September 7, 2022
Stereotactic Body Radiation Therapy vs Surgery for Early-Stage Non-Small Cell Lung Cancer: Does the Dealer Influence the Choice?Mohammad Jafferji, Daniel A Hamstra, Shawn S Groth
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
In Regard to Morris et alDaniel A Hamstra, Daniel Krauss, Mark K Buyyounouski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Diffusion magnetic resonance imaging: a biomarker for treatment response in oncologyDaniel A Hamstra, Alnawaz Rehemtulla, Brian D Ross
Cancers|February 15, 2022
Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer-Where Are We Now?Arpit Rao, Nagaishwarya Moka, Daniel A Hamstra, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Molecular Pharmacology|November 6, 2007
Revoking the privilege: targeting HER2 in the central nervous systemJoseph N Contessa, Daniel A Hamstra
International Journal of Radiation Oncology, Biology, Physics|June 25, 2021
Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient ExperienceJacob S Parzen, Daniel A Hamstra
Pediatric Blood & Cancer|February 15, 2008
Radiation therapy reduces local failure and improves overall survival in sPNETAaron C Spalding, Daniel A Hamstra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to G. Gandaglia et al and K. LuDean A Shumway, Daniel A Hamstra
Translational Andrology and Urology|July 18, 2020
Local control mattersRonald B Levitin, Daniel A Hamstra
Frontiers in Oncology|October 13, 2012
General commentary to the "management of biochemical recurrence after primary localized therapy for prostate cancer" by darwish o. M. And raj g. VMark Shilkrut, Felix Feng, Daniel A Hamstra
The Annals of Thoracic Surgery|September 7, 2022
Stereotactic Body Radiation Therapy vs Surgery for Early-Stage Non-Small Cell Lung Cancer: Does the Dealer Influence the Choice?Mohammad Jafferji, Daniel A Hamstra, Shawn S Groth
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
In Regard to Morris et alDaniel A Hamstra, Daniel Krauss, Mark K Buyyounouski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Diffusion magnetic resonance imaging: a biomarker for treatment response in oncologyDaniel A Hamstra, Alnawaz Rehemtulla, Brian D Ross
Cancers|February 15, 2022
Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer-Where Are We Now?Arpit Rao, Nagaishwarya Moka, Daniel A Hamstra, et al.
Pageof 13